Overview

A Study to Investigate the Effect of Itraconazole on the Way the Body Absorbs, Distributes, and Gets Rid of ACT-1004-1239 Given as a Single Dose of 10 mg to Healthy Male Subjects

Status:
Not yet recruiting

Trial end date:
2022-10-20

Target enrollment:

Participant gender:

Summary

A study to investigate the effect of itraconazole on the way the body absorbs, distributes, and gets rid of ACT-1004-1239 given as a single dose of 10 mg to healthy male subjects

Phase:

Phase 1

Details

Lead Sponsor:

Idorsia Pharmaceuticals Ltd.

Treatments:

Itraconazole